News Focus
News Focus
Followers 308
Posts 37304
Boards Moderated 1
Alias Born 11/14/2013

Re: attilathehunt post# 599819

Thursday, 06/08/2023 2:08:29 PM

Thursday, June 08, 2023 2:08:29 PM

Post# of 822629
Imo, for the most part, definitely. Particularly when combined with adjuvants like poly-iclc, csf1R and Keytruda — amongst others.

(Of course, it is possible that DCDirect version 3.0 and/or hyperactive dendritic cell therapy will reduce the need for any adjuvants)
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News